Thought Leadership on DCTs

ACRO’s White Paper provides an overview of key issues in the decentralization of clinical trials.  And, ACRO’s DCT Toolkit includes four resources:  (1) a detailed QbD Manual for DCTs; (2) an accessible, quick-reference QbD Manual; (3) a Risk Assessment Considerations template; and (4) DCT Data Flow Maps

• • ACRO DCT White Paper: A New Quality-by-Design, Risk-Based Framework
  • Bringing the Trial to the Patient: A Quality-by-Design Manual for Decentralized Clinical Trials
  • QbD Manual for Decentralized Clinical Trials: The Quick Reference Guide
  • Decentralized Clinical Trials Risk Assessment Considerations
  • Decentralized Clinical Trials Data Flow Maps

Advancing DCTs

ACRO members are dedicated to helping bring quality-based principles, risk-assessment tools, and patient-centricity to the decentralized trials process.

Explore some of ACRO’s additional DCT resources:

• Press Release
• ACRO Op Ed in Pharma Letter: Realizing the promise of decentralized trials
• White Paper feature in DIA Global Forum October 2020